comparemela.com

Latest Breaking News On - Aston sci inc - Page 1 : comparemela.com

US FDA Approves Aston Sci s Phase 2 IND for Ovarian Cancer Vaccine, AST-201

/PRNewswire/ Aston Sci. is proud to announce that it has received Phase 2 Clinical Investigational New Drug (IND) approval from the U.S. Food and Drug.

United statesSoult ukpyolsiSouth koreaShun jungPublic affairsRd division at aston sciDrug administrationNew vaccine approachOvarian cancerInvestigational new drugPrimary objectivePipeline expansionOvarian cancer patientsAston sci inc

Aston Sci Receives IND Approval from U S FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

/PRNewswire/ Aston Sci. Inc., a clinical stage biopharmaceutical company specializing in clinical development of therapeutic cancer vaccines, announced that.

Soult ukpyolsiSouth koreaUnited statesMaryl nora disisEun kyo joungUniversity of washingtonAmerican society of clinical oncologyRegulatory affairsDrug administrationAmerican societyClinical oncologyRegulatory affairs directorKyo joungChief medical officerAston sciAston sci inc

vimarsana © 2020. All Rights Reserved.